The Best of TPMG

🌟 Editorial 🌟: Welcome to September!

Hello, everyone!

We're back with another edition of our newsletter, packed with curated articles that reflect the essence of our vibrant community. From industry insights to personal reflections, each piece offers a unique perspective and valuable wisdom.

As always, we encourage you to engage with fellow members on LinkedIn, share your thoughts, and contribute to our collective learning. Plus, don't miss the opportunity to add your business to The Guide of The Pharmaceutical Marketing Group at theguide.tpmg.pro .

Thank you for being a part of our journey. Let's make September a month of growth and connection!

Warm regards,

Lucia Muniz | Editor

The Pharmaceutical Marketing Group

Featured Posts from The Pharmaceutical Marketing Group

Lucy Muniz encourages you to elevate your pharma launches with our webinar on September 24th. Discover how AI can transform your strategies and enhance customer satisfaction by learning from leading industry experts. Link to Lucy Muniz's LinkedIn post . #PharmaMarketing #AIInnovation #CustomerSatisfaction

Dorothy Gemmell , Chief Commercial Officer & President at GoodRx, is looking forward to participating at Digital Pharma East 2024 next week in Philadelphia. She will be part of a workshop on 9/9 with Michelle Davey, sponsored by Wheel, and a panel on 9/10 moderated by Divya Iyer, featuring speakers from AstraZeneca and Sanofi. Don’t miss the GoodRx Puppy Park benefiting Misfit Angels of South Jersey, and explore the latest trends in direct-to-patient solutions. Read more: Link to Dorothy Gemmell's LinkedIn post .

Philippe Auvaro , Executive Director at Medical Data Vision Co., Ltd, discusses the Japan Ministry of Health, Labor and Welfare’s proposal to revise fees for the cloud-based anonymous health insurance information database (NDB). The proposed changes aim to reform the use of real-world data, increasing fees compared to the current hard disk-based system, with new fee structures and caps in place. The revisions are part of broader efforts to enhance healthcare data utilization in Japan. Read more: Link to Philippe Auvaro's LinkedIn post .

Casper Nervil , MBA & Life Sciences Director, shares his excitement for the upcoming Life Sciences Business Strategy & Marketing course, featuring executive students from top companies like Novo Nordisk, WS Audiology, Coloplast, and more. This course, part of AVT Business School's accredited Executive Diploma and Executive MBA in Life Sciences programs, will include frameworks, trends, and real-life business cases. Special guest Professor Tim Calkins from Kellogg will join the discussions! Link to Casper Nervil's LinkedIn post .

Richard C. Hlavacek Jr. from LexisNexis Risk Healthcare shares insights on their latest whitepaper: "Improving Medication Adherence with Social Determinants of Health (SDoH)." Discover how SDoH data can enhance patient care, improve medication adherence, and reduce healthcare costs. Key takeaways include the impact of SDoH, integration strategies, and real-world success stories. Don't miss this valuable resource! #HealthcareInnovation #SDoH #MedicationAdherence #PatientCare #HealthcareData Link to Richard C. Hlavacek Jr.'s LinkedIn post.

Saulo Prado from The Lancet and the European Society of Cardiology share valuable content to healthcare professionals. If you work in marketing or medical affairs at a pharmaceutical company, you may find this collaboration particularly relevant. To learn more about connecting with a qualified audience through this content, please contact Saulo Prado. Link to Saulo Prado's LinkedIn post .

Michael D. Wolf, Ph.D. from Ochsner Health/Ochsner Fitness Center announces that HealthExecWire is seeking webinar speakers on Healthcare Marketing. Targeting an audience of over 100,000 healthcare providers and payers, this opportunity is ideal for professionals specializing in financial and operational performance. Interested speakers are encouraged to contact Publisher Adam Goldstein via email at adamg@mcol.com or connect with him on LinkedIn. Link to Michael D. Wolf, Ph.D.'s LinkedIn post .

Brooke Haddock from Data Discern Bridges invites you to join the effort in raising awareness for Polycystic Kidney Disease (PKD), the fourth leading cause of kidney failure in the US. Learn more about the disease types, ADPKD and ARPKD, and their impacts on patients. Resources to deepen your understanding are available through the provided links. Let’s amplify the message and support those affected by this rare condition. #PKDAwarenessDay #RareDisease #Healthcare #Patients #ClinicalTrials Link to Brooke Haddock's LinkedIn post .

See you in our next edition!